Clinical Nuclear Medicine

Skip Navigation LinksHome > July 2013 - Volume 38 - Issue 7 > Combined 18F-FDG PET/CT and 99mTc 3PRGD2 SPECT/CT Imaging in...
Clinical Nuclear Medicine:
doi: 10.1097/RLU.0b013e318292aa2f
Interesting Images

Combined 18F-FDG PET/CT and 99mTc 3PRGD2 SPECT/CT Imaging in a Case of Pituitary Metastases

Hou, Yuantao MD; Zhu, Zhaohui MD*; Jin, Xiaona MD*; Wang, Renzhi MD; Xing, Bing MD

Collapse Box


Abstract: We compare 18F-FDG PET/CT and 99mTc 3PRGD2 SPECT/CT scans in a case of histologically proved pituitary metastases. The ratio of tumor to cerebellum (T/C) of 99mTc 3PRGD2 SPECT is much higher than that for 18F-FDG PET. We then conduct the same scans for a pituitary adenoma patient for better comparison. The T/C of 18F-FDG is not able to differentiate pituitary metastases from pituitary adenoma. However, The T/C of 99mTc 3PRGD2 observed in pituitary metastases was higher than that in pituitary adenoma.

© 2013 by Lippincott Williams & Wilkins


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.